Sphaera Pharma Research And Development Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2008.

2008 New Delhi, Delhi, India Active

Last Updated: January 06, 2026

About Sphaera Pharma Research And Development Private Limited

Sphaera Pharma Research And Development Private Limited, a active private limited company, was established on 28 November 2008 in New Delhi, Delhi, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24232DL2008PTC224719. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.

It upholds a compliant status. Its leadership includes Abhinav Dhandia (Director), Ashish Dugar (Director). Past directors included Krishnamoorthy Narayanasamy, Amit Chander, Somdutta Sen. It holds no open charges and ₹1.19 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-5/110, Indra Enclave, Neb Sarai,, New Delhi, Delhi, 110068.

Company Details

CIN/LLPIN
U24232DL2008PTC224719
Registration Number
224719
Incorporation Date
28 November 2008
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.20 M
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.50 M as on 06-01-2026
Paid Up Capital ₹ 0.20 M as on 06-01-2026
Company Age 17 Year, 4 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 1.19 Cr as on 06-01-2026
Revenue Growth **** -64.81% (FY 2023)
Profit Growth **** -18370.60% (FY 2023)
Ebitda **** -75.21% (FY 2023)
Net Worth -41.22% (FY 2023)
Total Assets -88.12% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Sphaera Pharma Research And Development Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sphaera Pharma Research And Development Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Abhinav Dhandia	Director	08 Jan 2013	Current
Ashish Dugar	Director	02 Dec 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	22 Feb 2013	Past
Pramod Abcsdd	Director	01 Nov 2010	Past
Pramod Abcsdd	Additional Director	30 Oct 2021	Past
Pramod Abcsdd	Additional Director	30 Sep 2013	Past
Pramod Abcsdd	Additional Director	25 Sep 2023	Past
Pramod Abcsdd	Director	05 Dec 2009	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sphaera Pharma Research And Development.

Sphaera Pharma Research And Development Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 64.81% decrease. The company also saw a substantial fall in profitability, with a 18370.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.22%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-64.81%

*******

Revenue from Operations

*******

-10.11%

*******

Total Assets

*******

-88.12%

*******

Profit or Loss

*******

-18370.60%

*******

Net Worth

*******

-41.22%

*******

EBITDA

*******

-75.21%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sphaera Pharma Research And Development?

Unlock access to Sphaera Pharma Research And Development's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹11,856,000.00

Charges Breakdown by Lending Institutions

Biotechnology Industry Research Assistance Council : 1.19 Cr

Latest Charge Details

Date	Lender	Amount	Status
16 Dec 2011	Biotechnology Industry Research Assistance Council	₹1.19 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sphaera Pharma Research And Development?

Unlock and access historical data on people associated with Sphaera Pharma Research And Development, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sphaera Pharma Research And Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sphaera Pharma Research And Development's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sphaera Pharma Research And Development

Recent Activity within the Organization

Annual General Meeting

Sphaera Pharma Research And Development Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was recorded as a recent event.
26 Sep 2025
Balance Sheet

Progress on Sphaera Pharma Research And Development Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
31 Mar 2025
Director Appointment

Ashish Dugar was appointed as a Director was appointed as a Director on 02 Dec 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.
02 Dec 2022
Charges

A charge registered on 16 Dec 2011 via Charge ID 10324013 with Biotechnology Industry Research Assistance Council was fully satisfied on 11 Jun 2021. was recorded as a recent event.
11 Jun 2021
Charges

A charge with Biotechnology Industry Research Assistance Council of Rs. 11.86 M registered on 16 Dec 2011 with Charge ID 10324013 was modified on 22 Jan 2016. was recorded as a recent event.
22 Jan 2016
Director Appointment

Abhinav Dhandia was appointed as a Director was appointed as a Director on 08 Jan 2013 & has been associated with this company since 13 years 3 months . was recorded as a recent event.
08 Jan 2013

Explore recent activity and updates - View Recent Activity